Mankind Pharma Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 2,998.01 | 2,708.52 | 2,689.20 |
| Operating Expense | 2,035.47 | 1,685.80 | 1,937.86 |
| Net Profit | 558.49 | 713.61 | 448.88 |
| Net Profit Margin | 18.63% | 26.35% | 16.69% |
| Earning Per Share | 13.53 | 17.29 | 10.87 |
| EBIDTA | 929.80 | 1,110.30 | 816.49 |
| Effective Tax Rate | 17.18% | 15.84% | 16.18% |
Particulars
Jun 2026
Revenue2,998.01
Operating Expense2,035.47
Net Profit558.49
Net Profit Margin18.63
Earning Per Share13.53
EBIDTA929.80
Effective Tax Rate17.18
